Sanjivani Paranteral Limited. (SANJIVIN.BO)
INR 236.8
(-1.04%)
INR 236.8
(-1.04%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 87.58 Million INR | 44.96% |
| 2022 | 61.9 Million INR | 3.85% |
| 2021 | 59.65 Million INR | 56.18% |
| 2020 | 23.97 Million INR | 146.09% |
| 2019 | -1.7 Million INR | -58.92% |
| 2018 | -8.41 Million INR | 121.12% |
| 2017 | -517.37 Million INR | -24.69% |
| 2016 | -195.43 Million INR | -141.18% |
| 2015 | -47.95 Million INR | -186.08% |
| 2014 | 65.61 Million INR | -43.04% |
| 2013 | 120.78 Million INR | -7.38% |
| 2012 | 119.98 Million INR | -2.48% |
| 2011 | 127.09 Million INR | 16.0% |
| 2010 | 109.97 Million INR | -11.21% |
| 2009 | 115.34 Million INR | 42.99% |
| 2008 | 82.11 Million INR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 32.41 Million INR | 33.83% |
| 2024 Q1 | 23.36 Million INR | 9.6% |
| 2023 Q4 | 21.57 Million INR | -2.49% |
| 2023 FY | - INR | 44.96% |
| 2023 Q1 | 20.71 Million INR | 64.85% |
| 2023 Q2 | 22.63 Million INR | 9.3% |
| 2023 Q3 | 22.12 Million INR | -2.26% |
| 2022 FY | - INR | 3.85% |
| 2022 Q4 | 12.56 Million INR | 1.97% |
| 2022 Q3 | 12.32 Million INR | -5.16% |
| 2022 Q1 | 22.74 Million INR | 39.89% |
| 2022 Q2 | 12.99 Million INR | -42.87% |
| 2021 Q2 | 14.05 Million INR | 68.52% |
| 2021 Q4 | 16.25 Million INR | -17.61% |
| 2021 FY | - INR | 56.18% |
| 2021 Q1 | 8.34 Million INR | -45.06% |
| 2021 Q3 | 19.73 Million INR | 40.38% |
| 2020 Q3 | 4.96 Million INR | -0.92% |
| 2020 FY | - INR | 146.09% |
| 2020 Q1 | -2.36 Million INR | -181.35% |
| 2020 Q4 | 15.18 Million INR | 205.9% |
| 2020 Q2 | 5.01 Million INR | 312.2% |
| 2019 Q2 | -175 Thousand INR | 90.19% |
| 2019 Q4 | 2.9 Million INR | 192.28% |
| 2019 FY | - INR | -58.92% |
| 2019 Q1 | -1.78 Million INR | -179.1% |
| 2019 Q3 | -3.14 Million INR | -1697.14% |
| 2018 Q3 | -4.28 Million INR | 56.92% |
| 2018 Q2 | -9.95 Million INR | -502.59% |
| 2018 Q1 | 2.47 Million INR | 101.25% |
| 2018 FY | - INR | 121.12% |
| 2018 Q4 | 2.25 Million INR | 152.56% |
| 2017 Q1 | -60.07 Million INR | 68.09% |
| 2017 FY | - INR | -24.69% |
| 2017 Q2 | -243.36 Million INR | -305.08% |
| 2017 Q3 | -16.63 Million INR | 93.16% |
| 2017 Q4 | -197.29 Million INR | -1085.96% |
| 2016 Q1 | 3.82 Million INR | 102.79% |
| 2016 FY | - INR | -141.18% |
| 2016 Q4 | -188.25 Million INR | -1083.81% |
| 2016 Q3 | -15.9 Million INR | -307.12% |
| 2016 Q2 | -3.9 Million INR | -202.09% |
| 2015 Q1 | 27.49 Million INR | 477.16% |
| 2015 FY | - INR | -186.08% |
| 2015 Q4 | -136.95 Million INR | -609.19% |
| 2015 Q3 | 26.89 Million INR | -22.28% |
| 2015 Q2 | 34.6 Million INR | 25.85% |
| 2014 Q3 | 23.08 Million INR | -4.73% |
| 2014 FY | - INR | -43.04% |
| 2014 Q4 | -7.29 Million INR | -131.58% |
| 2014 Q1 | 27.96 Million INR | 56.1% |
| 2014 Q2 | 24.23 Million INR | -13.35% |
| 2013 Q3 | 38.61 Million INR | 42.38% |
| 2013 Q4 | 17.91 Million INR | -53.61% |
| 2013 FY | - INR | -7.38% |
| 2013 Q1 | 27.5 Million INR | -0.96% |
| 2013 Q2 | 27.12 Million INR | -1.38% |
| 2012 Q2 | 26.19 Million INR | -18.24% |
| 2012 FY | - INR | -2.48% |
| 2012 Q1 | 32.03 Million INR | 20.44% |
| 2012 Q4 | 27.76 Million INR | 6.01% |
| 2012 Q3 | 26.19 Million INR | 0.0% |
| 2011 Q3 | 33.3 Million INR | 0.0% |
| 2011 FY | - INR | 16.0% |
| 2011 Q4 | 26.59 Million INR | -20.13% |
| 2010 FY | - INR | -11.21% |
| 2009 FY | - INR | 42.99% |
| 2008 FY | - INR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| ANG Lifesciences India Limited | 90.66 Million INR | 3.397% |
| Add-Shop E-Retail Limited | 82.61 Million INR | -6.013% |
| Bacil Pharma Limited | -569.32 Thousand INR | 15483.709% |
| Beryl Drugs Limited | 26.63 Million INR | -228.776% |
| Cian Healthcare Limited | 122.56 Million INR | 28.543% |
| Colinz Laboratories Limited | 5.42 Million INR | -1513.532% |
| Concord Drugs Limited | 40.52 Million INR | -116.146% |
| Deccan Health Care Limited | 37.5 Million INR | -133.516% |
| Gennex Laboratories Limited | 219.35 Million INR | 60.073% |
| Gujarat Terce Laboratories Limited | 15.87 Million INR | -451.631% |
| Ishita Drugs and Industries Limited | 11.88 Million INR | -636.731% |
| Kerala Ayurveda Limited | 70.78 Million INR | -23.727% |
| Kwality Pharmaceuticals Limited | 610.44 Million INR | 85.653% |
| Mercury Laboratories Limited | 101.18 Million INR | 13.446% |
| Panchsheel Organics Limited | 189.36 Million INR | 53.75% |
| Parmax Pharma Limited | 22.93 Million INR | -281.831% |
| Parnax Lab Limited | 243.59 Million INR | 64.046% |
| Patidar Buildcon Limited | -5.52 Million INR | 1684.917% |
| Pharmaids Pharmaceuticals Limited | -123.28 Million INR | 171.042% |
| Phaarmasia Limited | -1.58 Million INR | 5636.19% |
| Sandu Pharmaceuticals Limited | 27.19 Million INR | -222.077% |
| Sastasundar Ventures Limited | -203.51 Million INR | 143.035% |
| SHELTER PHARMA LIMITED | 89.01 Million INR | 1.604% |
| Source Natural Foods and Herbal Supplements Limited | 44.8 Million INR | -95.479% |
| SUDARSHAN PHARMA INDUSTRIES LI | 254.17 Million INR | 65.542% |
| Sunil Healthcare Limited | 93.07 Million INR | 5.905% |
| Syschem (India) Limited | 70.4 Million INR | -24.405% |
| Trident Lifeline Limited | 102.69 Million INR | 14.714% |
| Transchem Limited | 56.61 Million INR | -54.709% |
| Tyche Industries Limited | 128.2 Million INR | 31.687% |
| Vikram Thermo (India) Limited | 386.92 Million INR | 77.364% |
| Vasundhara Rasayans Limited | 84.22 Million INR | -3.985% |
| Zenith Healthcare Limited | 4.98 Million INR | -1655.865% |
| Zenotech Laboratories Limited | 172.64 Million INR | 49.27% |
| Hindustan Bio Sciences Limited | 638.75 Thousand INR | -13611.465% |
| KIMIA BIOSCIENCES LIMITED | 11.58 Million INR | -656.065% |
| Chemo Pharma Laboratories Limited | 16.51 Million INR | -430.225% |
| MedPlus Health Services Limited | 3.94 Billion INR | 97.778% |
| Smruthi Organics Limited | 120.31 Million INR | 27.204% |
| Trimurthi Limited | -2.47 Million INR | 3633.677% |
| Zenlabs Ethica Limited | 27.09 Million INR | -223.23% |
| Makers Laboratories Limited | 25.81 Million INR | -239.309% |
| Lactose (India) Limited | 201.22 Million INR | 56.475% |
| Bharat Immunologicals & Biologicals Corporation Limited | -151.05 Million INR | 157.981% |
| Roopa Industries Limited | 55.7 Million INR | -57.237% |
| PANJON LTD. | 4.08 Million INR | -2041.906% |
| TIAAN CONSUMER LIMITED | -19.05 Million INR | 559.703% |
| Anuh Pharma Limited | 878.5 Million INR | 90.03% |
| Crestchem Limited | 30.33 Million INR | -188.724% |
| Emmessar Biotech & Nutrition Limited | -10.81 Million INR | 909.6% |
| PRAVEG LIMITED | 321.43 Million INR | 72.753% |
| Fredun Pharmaceuticals Limited | 388.97 Million INR | 77.484% |
| Shukra Pharmaceuticals Limited | 216.59 Million INR | 59.564% |
| Norris Medicines Limited | -1.78 Million INR | 5008.936% |
| Denis Chem Lab Limited | 224.84 Million INR | 61.048% |
| Veerhealth Care Limited | 15.99 Million INR | -447.562% |
| Jenburkt Pharmaceuticals Limited | 377.86 Million INR | 76.821% |
| OXYGENTA PHARMACEUTICAL LIMITE | -96.17 Million INR | 191.07% |
| Godavari Drugs Limited | 134.62 Million INR | 34.943% |
| SHAMROCK INDUSTRIAL CO.LTD. | -406 Thousand INR | 21672.052% |
| Ambalal Sarabhai Enterprises Limited | 170.57 Million INR | 48.654% |
| Vivanza Biosciences Limited | 11.2 Million INR | -681.708% |
| Medi-Caps Limited | 4.77 Million INR | -1735.727% |
| DECIPHER LABS LIMITED | -2.72 Million INR | 3319.946% |
| Shree Ganesh Remedies Limited | 448.77 Million INR | 80.484% |
| Gujarat Themis Biosyn Limited | 830.99 Million INR | 89.461% |
| Bharat Parenterals Limited | 265.74 Million INR | 67.042% |
| BDH Industries Limited | 124.27 Million INR | 29.524% |
| Vista Pharmaceuticals Limited | -32.37 Million INR | 370.492% |
| Coral Laboratories Limited | 227.07 Million INR | 61.43% |
| Evoq Remedies Limited | 6.18 Million INR | -1315.367% |
| Trinity League India Limited | -26.25 Million INR | 433.61% |
| KOBO BIOTECH LIMITED | -8.57 Million INR | 1121.609% |
| Natural Capsules Limited | 219.9 Million INR | 60.172% |
| Auro Laboratories Limited | 121.73 Million INR | 28.055% |